{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:55Z","timestamp":1792788115860,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Universit\u00e9 Clermont Auvergne"},{"name":"CHU Clermont-Ferrand"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,27]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The dual enkephalinase inhibitor PL37, a small molecule that protects enkephalins from rapid degradation, has demonstrated analgesic properties in animal pain models and in early human clinical trials. This study tested the antimigraine potential of PL37 on cutaneous mechanical hypersensitivity affecting cephalic regions in migraineurs.<\/jats:p><jats:p>Using behavioural testing and c-Fos immunoreactivity in male rats, we investigated the effects of single (oral or intravenous) and repeated oral administration of PL37 on changes in cutaneous mechanical sensitivity and sensitization of the trigeminocervical complex induced by repeated administration of the nitric oxide donor, isosorbide dinitrate.<\/jats:p><jats:p>In na\u00efve rats, single or repeated administration of PL37 or vehicle had no effect on cephalic mechanical sensitivity. However, single oral PL37 treatment effectively inhibited isosorbide dinitrate-induced acute cephalic mechanical hypersensitivity. Single intravenous but not oral PL37 administration inhibited chronic cephalic mechanical hypersensitivity. Daily oral administration of PL37 prevented cephalic mechanical hypersensitivity and decreased touch-induced c-Fos expression in trigeminocervical complex following repeated isosorbide dinitrate administration.<\/jats:p><jats:p>These data reveal the therapeutic potential of the dual enkephalinase inhibitor PL37 as an acute and prophylactic treatment for migraine. Protecting enkephalins from their degrading enzymes therefore appears to be an innovative approach to treat migraine.<\/jats:p>","DOI":"10.1093\/brain\/awac139","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T06:58:17Z","timestamp":1649746697000},"page":"2664-2670","source":"Crossref","is-referenced-by-count":18,"title":["Dual enkephalinase inhibitor PL37 as a potential novel treatment of migraine: evidence from a rat model"],"prefix":"10.1093","volume":"145","author":[{"given":"Am\u00e9lie","family":"Descheemaeker","sequence":"first","affiliation":[{"name":"Universit\u00e9 Clermont Auvergne, CHU Clermont-Ferrand, Inserm, Neuro-Dol , F-63000 Clermont-Ferrand , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Poras","sequence":"additional","affiliation":[{"name":"Pharmaleads SA , F-75013 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Wurm","sequence":"additional","affiliation":[{"name":"Pharmaleads SA , F-75013 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Luccarini","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Clermont Auvergne, CHU Clermont-Ferrand, Inserm, Neuro-Dol , F-63000 Clermont-Ferrand , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Ouimet","sequence":"additional","affiliation":[{"name":"Pharmaleads SA , F-75013 Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7494-116X","authenticated-orcid":false,"given":"Radhouane","family":"Dallel","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Clermont Auvergne, CHU Clermont-Ferrand, Inserm, Neuro-Dol , F-63000 Clermont-Ferrand , France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"issue":"10283","key":"2022082719583860400_awac139-B1","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(20)32342-4","article-title":"Migraine: integrated approaches to clinical management and emerging treatments","volume":"397","author":"Ashina","year":"2021","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"2022082719583860400_awac139-B2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1526-4610.2007.00752.x","article-title":"Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden","volume":"47","author":"Bigal","year":"2007","journal-title":"Headache"},{"key":"2022082719583860400_awac139-B3","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15656","article-title":"The inhibition of enkephalin catabolism by dual enkephalinase inhibitor: a novel possible therapeutic approach for opioid use disorders","author":"Alvarez-Perez","year":"11 2021","journal-title":"Br J Pharmacol"},{"issue":"4","key":"2022082719583860400_awac139-B4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrd3673","article-title":"Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain","volume":"11","author":"Roques","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"21","key":"2022082719583860400_awac139-B5","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1073\/pnas.2000712117","article-title":"Biased signaling by endogenous opioid peptides","volume":"117","author":"Gomes","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2022082719583860400_awac139-B6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0333102417714032","article-title":"Recurrent administration of the nitric oxide donor, isosorbide dinitrate, induces a persistent cephalic cutaneous hypersensitivity: a model for migraine progression","volume":"38","author":"Dallel","year":"2018","journal-title":"Cephalalgia Int J Headache"},{"issue":"7","key":"2022082719583860400_awac139-B7","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.pain.2014.03.001","article-title":"General trigeminospinal central sensitization and impaired descending pain inhibitory controls contribute to migraine progression","volume":"155","author":"Boyer","year":"2014","journal-title":"Pain"},{"issue":"1","key":"2022082719583860400_awac139-B8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/brain\/awy313","article-title":"Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity","volume":"142","author":"Akerman","year":"2019","journal-title":"Brain"},{"issue":"14","key":"2022082719583860400_awac139-B9","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1177\/0333102419861726","article-title":"Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain","volume":"39","author":"Christensen","year":"2019","journal-title":"Cephalalgia Int J Headache"},{"issue":"49","key":"2022082719583860400_awac139-B10","doi-asserted-by":"crossref","first-page":"10489","DOI":"10.1523\/JNEUROSCI.1294-18.2018","article-title":"5-HT2A receptor-induced morphological reorganization of PKC\u03b3-expressing interneurons gates inflammatory mechanical allodynia in rat","volume":"38","author":"Alba-Delgado","year":"2018","journal-title":"J Neurosci"},{"key":"2022082719583860400_awac139-B11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuropharm.2018.12.017","article-title":"Delta opioid receptor agonists are effective for multiple types of headache disorders","volume":"148","author":"Moye","year":"2019","journal-title":"Neuropharmacology"},{"issue":"2","key":"2022082719583860400_awac139-B12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pain.2013.10.004","article-title":"Characterization of a novel model of chronic migraine","volume":"155","author":"Pradhan","year":"2014","journal-title":"Pain"},{"issue":"13","key":"2022082719583860400_awac139-B13","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1021\/jm500602h","article-title":"New orally active dual enkephalinase inhibitors (DENKIs) for central and peripheral pain treatment","volume":"57","author":"Poras","year":"2014","journal-title":"J Med Chem"},{"issue":"6","key":"2022082719583860400_awac139-B14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1526-4610.1989.hed2906368.x","article-title":"Endogenous opioid-like peptides in headache. an overview","volume":"29","author":"Mosnaim","year":"1989","journal-title":"Headache"},{"issue":"3","key":"2022082719583860400_awac139-B15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1526-4610.1990.hed3003160.x","article-title":"Methionine-enkephalin in migraine and tension headache. Differences between classic migraine, common migraine and tension headache, and changes during attacks","volume":"30","author":"Ferrari","year":"1990","journal-title":"Headache"},{"issue":"1","key":"2022082719583860400_awac139-B16","doi-asserted-by":"crossref","first-page":"8967","DOI":"10.1038\/ncomms9967","article-title":"Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7","volume":"6","author":"Minett","year":"2015","journal-title":"Nat Commun"},{"issue":"2","key":"2022082719583860400_awac139-B17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3988\/jcn.2012.8.2.89","article-title":"Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology","volume":"8","author":"Bernstein","year":"2012","journal-title":"J Clin Neurol"},{"issue":"10","key":"2022082719583860400_awac139-B18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1468-2982.2008.01654.x","article-title":"Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia","volume":"28","author":"Schoenen","year":"2008","journal-title":"Cephalalgia"},{"issue":"1","key":"2022082719583860400_awac139-B19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10194-007-0354-7","article-title":"Sumatriptan 6\u2005mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptans","volume":"8","author":"Diamond","year":"2007","journal-title":"J Headache Pain"},{"issue":"10","key":"2022082719583860400_awac139-B20","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1097\/j.pain.0000000000001007","article-title":"Propranolol treatment prevents chronic central sensitization induced by repeated dural stimulation","volume":"158","author":"Boyer","year":"2017","journal-title":"Pain"},{"issue":"21","key":"2022082719583860400_awac139-B21","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1111\/bph.14462","article-title":"Effects of systemic inhibitors of acid-sensing ion channels 1 (ASIC1) against acute and chronic mechanical allodynia in a rodent model of migraine: ASIC1 channel inhibitors against acute and chronic migraine","volume":"175","author":"Verkest","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"14","key":"2022082719583860400_awac139-B22","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1177\/0333102416677051","article-title":"Anatomy and immunochemical characterization of the non-arterial peptidergic diffuse dural innervation of the rat and Rhesus monkey: implications for functional regulation and treatment in migraine","volume":"37","author":"Rice","year":"2017","journal-title":"Cephalalgia"},{"key":"2022082719583860400_awac139-B23","doi-asserted-by":"crossref","first-page":"108375","DOI":"10.1016\/j.neuropharm.2020.108375","article-title":"Characterization of opioidergic mechanisms related to the anti-migraine effect of vagus nerve stimulation","volume":"195","author":"Hu","year":"2021","journal-title":"Neuropharmacology"},{"issue":"8","key":"2022082719583860400_awac139-B24","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1097\/j.pain.0000000000002235","article-title":"Delta opioid receptor regulation of calcitonin gene-related peptide dynamics in the trigeminal complex","volume":"162","author":"Moye","year":"2021","journal-title":"Pain"},{"issue":"2","key":"2022082719583860400_awac139-B25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0306-4522(87)90101-1","article-title":"The nuclei of origin of brainstem enkephalin and cholecystokinin projections to the spinal trigeminal nucleus of the rat","volume":"20","author":"Beitz","year":"1987","journal-title":"Neuroscience"},{"issue":"1","key":"2022082719583860400_awac139-B26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0166-2236(95)93946-U","article-title":"Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications","volume":"18","author":"Mansour","year":"1995","journal-title":"Trends Neurosci"},{"issue":"3","key":"2022082719583860400_awac139-B27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(86)90430-9","article-title":"Effects of opioids and opioid peptide on the release of substance P-like material induced by tooth pulp stimulation in the trigeminal nucleus caudalis of the rabbit","volume":"129","author":"Yonehara","year":"1986","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2022082719583860400_awac139-B28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of migraine: a disorder of sensory processing","volume":"97","author":"Goadsby","year":"2017","journal-title":"Physiol Rev"},{"issue":"3","key":"2022082719583860400_awac139-B29","first-page":"653","article-title":"Double-blind study of effects of enkephalinase inhibitor on adverse reactions to myelography","volume":"4","author":"Floras","year":"1983","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"2022082719583860400_awac139-B30","first-page":"201","article-title":"Potent analgesic effects of inhibitors of enkephalin metabolism administered intrathecally to cancer patients","volume":"2","author":"Meynadier","year":"1988","journal-title":"Pain Clin"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awac139\/45028471\/awac139.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/8\/2664\/45599868\/awac139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/8\/2664\/45599868\/awac139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T22:14:01Z","timestamp":1700432041000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/145\/8\/2664\/6566792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,4,12]]},"published-print":{"date-parts":[[2022,8,27]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awac139","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2022,4,12]]}}}